ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$2.39
+0.18 (+8.14%)
Open$2.24
Previous Close$2.21
Day High$2.39
Day Low$2.17
52W High$21.89
52W Low$17.84
Volume—
Avg Volume735.6K
Market Cap128.61M
P/E Ratio34.61
EPS$0.59
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+1,033.5% upside
Current
$2.39
$2.39
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.61M | 25.42M | 27.85M |
| Net Income | -2,223,610 | -1,538,415 | -1,953,169 |
| Profit Margin | -8.1% | -6.1% | -7.0% |
| EBITDA | -3,072,165 | -2,609,903 | -3,215,308 |
| Free Cash Flow | -1,433,660 | -1,157,693 | -1,340,683 |
| Rev Growth | +21.3% | +16.0% | +14.0% |
| Debt/Equity | 0.13 | 0.13 | 0.13 |
Dividend
Dividend Yield1.10%
Annual Dividend$0.22
Payout Ratio37.8%
Frequencyquarterly
Ex-DividendMar 15, 2026
Pay DateMar 26, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |